Clinical Trials on Intensive Care Risk Reduction in Switzerland
Total 36 results
-
Assistance Publique - Hôpitaux de ParisCompletedKidney Transplantation | Kidney Transplant Rejection | Prognosis | Risk StratificationFrance, Germany, Spain, Switzerland
-
Insel Gruppe AG, University Hospital BernNot yet recruitingRisk Reduction | Hypobaric Hypoxia | High AltitudeSwitzerland
-
Centre Hospitalier Universitaire VaudoisCompletedIntensive Care | Occupational TherapySwitzerland
-
University Hospital Inselspital, BerneCompletedBehavioral Changes | Pediatric Intensive Care Unit | Closed Loop Communication | In-situ SimulationSwitzerland
-
Hospices Civils de LyonCompletedPediatric Intensive Care UnitFrance, Belgium, Lebanon, Switzerland
-
Kantonsspital Winterthur KSWTerminatedPost Intensive Care Unit SyndromeSwitzerland
-
University of ZurichRecruitingLung Transplant Rejection | Lung Transplant Failure and RejectionSwitzerland
-
Michael RuferUniversity of ZurichEnrolling by invitationHealth Care Utilization | Chronic Psychiatric Disorder | Psychiatric Hospitalization | Intensive Care Psychiatric Disorder | Rehospitalization | High Utilization / Heavy UseSwitzerland
-
University of ZurichRecruitingChronic Rejection of Lung TransplantSwitzerland
-
University Hospital, GenevaUniversity Hospital, Rouen; Rabin Medical Center; University Hospital, Clermont-Ferrand and other collaboratorsCompletedIntensive Care Unit PatientsPoland, France, Israel, Belgium, Lithuania, Brazil, Croatia, Spain, Switzerland
-
University Hospital Inselspital, BerneNestec Ltd.CompletedMuscle Weakness | Intensive Care Unit (ICU) Acquired Weakness (ICU - AW)Switzerland
-
University Hospital, GenevaCompletedAnesthesia | Thoracotomy | Lung Injury, Acute | Extravascular Lung Water | Intensive Care, SurgicalSwitzerland
-
Psychiatric Hospital of the University of BaselActive, not recruitingHarm Reduction | Schizophrenia and Other Psychotic DisordersSwitzerland
-
University of ZurichKliniken ValensCompletedDisease With a Risk for ChronicitySwitzerland
-
University of ZurichSwiss Tropical & Public Health InstituteCompletedRisk Behavior | Travel Health | Mobile Health Technology (mHealth) | Elderly Travelers | Chronic Diseased TravelersSwitzerland
-
University Children's Hospital, ZurichUniversity of Lausanne Hospitals; University of Bern; University of Geneva, SwitzerlandRecruitingCongenital Heart Disease | Cardiac Disease | Neurodevelopmental Abnormality | Intensive Care Neurological DisorderSwitzerland
-
Insel Gruppe AG, University Hospital BernETH ZurichNot yet recruitingPediatric Oncology Patients With Risk for InfectionsSwitzerland
-
University of ZurichActive, not recruitingLung Transplant Rejection | Organizing PneumoniaSwitzerland
-
University Hospital, Basel, SwitzerlandCompletedHeart Attack | Coronary Artery Bypass Grafting (CABG) | Cardioplegia Solution Adverse ReactionSwitzerland
-
University Hospital, Basel, SwitzerlandRecruitingLung Resection | Postoperative Air LeakSwitzerland
-
Klinik ValensRecruitingMultiple Sclerosis, Chronic Progressive | High-Intensity Interval Training | Motor SymptomsSwitzerland
-
ETOP IBCSG Partners FoundationGlaxoSmithKline; Development LimitedRecruitingSCLC,Extensive Stage | SLFN11-positiveSwitzerland, France, Spain, Italy
-
Bern University of Applied SciencesUniversity of BernUnknownDepression | Anxiety Disorders | Post Traumatic Stress Disorder | Psychosis | Substance Abuse | Panic Disorder | Behavior Disorders | Mental Disorder | Health Care Utilization | Adaptation Reaction | Health Care Seeking Behavior | Health Care Acceptability | PerinatalSwitzerland
-
John O. PriorRecruitingCardiac Sarcoidosis | Acute Cellular Graft Rejection | Myocarditis Due to DrugSwitzerland
-
Assistance Publique - Hôpitaux de ParisRecruitingInitial Radiological Diagnosis Eligible for Tumor Resection | Initial Radiological Diagnosis Compatible With Newly Diagnosed Glioblastoma (IDH Wild-type) | Eligible for the Standard of Care Including Concurrent Temoradiation and Adjuvant TemozolomideBelgium, France, Switzerland
-
Sunnybrook Health Sciences CentreCompletedSepsis | Mortality | Bacteremia | Critically Ill | Intensive Care | AntimicrobialNew Zealand, United States, Canada, Australia, Switzerland, Saudi Arabia, Israel
-
Amsterdam UMCRecruitingBarrett Esophagus | Submucosal Esophageal Adenocarcinoma | High-risk Mucosal Esophageal AdenocarcinomaNetherlands, Belgium, Australia, United Kingdom, Germany, Switzerland
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownBarrett Esophagus | Adenocarcinoma Esophagus | Submucosal Esophageal Adenocarcinoma | High-risk Mucosal Esophageal AdenocarcinomaFrance, United Kingdom, Belgium, Germany, Switzerland, Australia, Netherlands
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
European Organisation for Research and Treatment...UNICANCERRecruitingExtensive-stage Small-cell Lung Cancer | Limited Stage Small Cell Lung CancerUnited Kingdom, Belgium, Switzerland, Italy, France, Germany, Poland, Spain, Austria
-
Gustave Roussy, Cancer Campus, Grand ParisRecruitingHigh-Risk Neuroblastoma | Patient With Insufficient Response ChemoimmunotherapyFrance, Germany, Israel, Spain, United Kingdom, Belgium, Norway, Sweden, Finland, Australia, Czechia, Italy, Netherlands, Slovenia, Switzerland, Denmark, Greece, Lithuania, Slovakia
-
AmgenTerminatedHigh-risk Diffuse Large B-cell LymphomaUnited States, Italy, Belgium, Switzerland, Australia, France, Greece
-
AmgenRecruitingExtensive Stage Small Cell Lung CancerKorea, Republic of, United States, Netherlands, Taiwan, Switzerland, Spain, Canada, Israel, Germany, France, Belgium, Australia, Japan, Italy, Denmark
-
BayerRecruitingAcute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic AttackUnited States, Switzerland, Belgium, Sweden, Canada, Australia, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, Greece, Japan, Turkey, Netherlands, Romania, China, United Kingdom, Portugal, Italy, France, Slovakia, Austria, Czechi... and more
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedB-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | Intermediate Risk Recurrent Childhood Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, Switzerland